HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activities.

Abstract
A number of bis(diazeniumdiolates) that we designed to release up to 4 mol of nitric oxide (NO) and that are structural analogues of the NO prodrug and anticancer lead compound O(2)-{2,4-dinitro-5-[4-(N-methylamino)benzoyloxy]phenyl} 1-(N,N-dimethylamino)diazen-1-ium-1,2- diolate (PABA/NO) were synthesized and studied. A majority of these compounds yielded higher levels of NO, were better inhibitors of proliferation of a number of cancer cell lines, and more rapidly induced substantially increased levels of S-glutathionylation of cellular proteins in comparison with PABA/NO. In most cases, the antiproliferative activity and extents of S-glutathionylation correlated well with levels of intracellular NO release. We report bis(diazeniumdiolates) to be a class of S-glutathionylating agents with potent antiproliferative and S-glutathionylating activity.
AuthorsDaniela Andrei, Anna E Maciag, Harinath Chakrapani, Michael L Citro, Larry K Keefer, Joseph E Saavedra
JournalJournal of medicinal chemistry (J Med Chem) Vol. 51 Issue 24 Pg. 7944-52 (Dec 25 2008) ISSN: 1520-4804 [Electronic] United States
PMID19053760 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
Chemical References
  • Azo Compounds
  • Nitric Oxide Donors
  • Prodrugs
  • diazeniumdiolate
  • Nitric Oxide
  • Glutathione
Topics
  • Azo Compounds (chemistry, pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Chemistry, Pharmaceutical (methods)
  • Drug Design
  • Drug Screening Assays, Antitumor
  • Glutathione (chemistry)
  • HL-60 Cells
  • Humans
  • Inhibitory Concentration 50
  • Models, Chemical
  • Nitric Oxide (chemistry)
  • Nitric Oxide Donors (chemistry)
  • Prodrugs (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: